Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Reid

Showing results (1421-1430 of 1,568) with videos related to

Pageof 157
Sort By:
The Journal of General Physiology|January 7, 2021
Proteomic and functional mapping of cardiac NaV1.5 channel phosphorylation sitesMaxime Lorenzini, Sophie Burel, Adrien Lesage, et al.
Cancer|April 23, 2013
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 studyJeffrey R Infante, Tony R Reid, Allen L Cohn, et al.
Military Medicine|September 23, 2025
Partial Resuscitative Endovascular Balloon Occlusion of the Aorta Versus Intermittent Resuscitative Endovascular Balloon Occlusion of the Aorta in Noncompressible Torso Hemorrhage With Concomitant Traumatic Brain InjuryGloria D Sanin, Elizabeth C Wood, Micaela K Gomez, et al.
Proteomics. Clinical Applications|December 8, 2010
A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screeningJanet S Rader, James P Malone, Julia Gross, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Activation of heme biosynthesis by a small molecule that is toxic to fermenting Staphylococcus aureusLaura A Mike, Brendan F Dutter, Devin L Stauff, et al.
Science (New York, N.Y.)|April 21, 2018
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2AAgostinho G Rocha, Antonietta Franco, Andrzej M Krezel, et al.
Biochemical Pharmacology|June 28, 1996
In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitorsD G Sawutz, D C Bode, G M Briggs, et al.
Cancer Gene Therapy|December 25, 2023
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumorsAnthony P Conley, Christina L Roland, Alberto Bessudo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 10, 2010
Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studiesIan R Reid, Paul D Miller, Jacques P Brown, et al.
Mbio|November 14, 2022
Type IV Pili Are a Critical Virulence Factor in Clinical Isolates of Paenibacillus thiaminolyticusChristine Hehnly, Aiqin Shi, Paddy Ssentongo, et al.
Pageof 157

Showing results (1421-1430 of 1,568) with videos related to

Sort By:
Pageof 157
The Journal of General Physiology|January 7, 2021
Proteomic and functional mapping of cardiac NaV1.5 channel phosphorylation sitesMaxime Lorenzini, Sophie Burel, Adrien Lesage, et al.
Cancer|April 23, 2013
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 studyJeffrey R Infante, Tony R Reid, Allen L Cohn, et al.
Military Medicine|September 23, 2025
Partial Resuscitative Endovascular Balloon Occlusion of the Aorta Versus Intermittent Resuscitative Endovascular Balloon Occlusion of the Aorta in Noncompressible Torso Hemorrhage With Concomitant Traumatic Brain InjuryGloria D Sanin, Elizabeth C Wood, Micaela K Gomez, et al.
Proteomics. Clinical Applications|December 8, 2010
A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screeningJanet S Rader, James P Malone, Julia Gross, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Activation of heme biosynthesis by a small molecule that is toxic to fermenting Staphylococcus aureusLaura A Mike, Brendan F Dutter, Devin L Stauff, et al.
Science (New York, N.Y.)|April 21, 2018
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2AAgostinho G Rocha, Antonietta Franco, Andrzej M Krezel, et al.
Biochemical Pharmacology|June 28, 1996
In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitorsD G Sawutz, D C Bode, G M Briggs, et al.
Cancer Gene Therapy|December 25, 2023
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumorsAnthony P Conley, Christina L Roland, Alberto Bessudo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 10, 2010
Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studiesIan R Reid, Paul D Miller, Jacques P Brown, et al.
Mbio|November 14, 2022
Type IV Pili Are a Critical Virulence Factor in Clinical Isolates of Paenibacillus thiaminolyticusChristine Hehnly, Aiqin Shi, Paddy Ssentongo, et al.
Pageof 157